Mendel Money Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Sell |
10,187
-43
| -0.4% | -$4.77K | 0.5% | 60 |
|
|
2025
Q1 | $1.15M | Buy |
10,230
+10
| +0.1% | +$1.12K | 0.54% | 53 |
|
|
2024
Q4 | $944K | Sell |
10,220
-25
| -0.2% | -$2.31K | 0.42% | 63 |
|
|
2024
Q3 | $859K | Buy |
10,245
+50
| +0.5% | +$4.19K | 0.37% | 70 |
|
|
2024
Q2 | $699K | Buy |
10,195
+225
| +2% | +$15.4K | 0.33% | 73 |
|
|
2024
Q1 | $730K | Buy |
9,970
+180
| +2% | +$13.2K | 0.34% | 71 |
|
|
2023
Q4 | $793K | Buy |
9,790
+524
| +6% | +$42.4K | 0.38% | 61 |
|
|
2023
Q3 | $694K | Buy |
9,266
+706
| +8% | +$52.9K | 0.37% | 59 |
|
|
2023
Q2 | $660K | Buy |
8,560
+75
| +0.9% | +$5.78K | 0.34% | 62 |
|
|
2023
Q1 | $704K | Buy |
8,485
+115
| +1% | +$9.54K | 0.38% | 58 |
|
|
2022
Q4 | $719K | Sell |
8,370
-30
| -0.4% | -$2.58K | 0.41% | 55 |
|
|
2022
Q3 | $518K | Buy |
8,400
+3,230
| +62% | +$199K | 0.32% | 62 |
|
|
2022
Q2 | $320K | Sell |
5,170
-3,145
| -38% | -$195K | 0.19% | 87 |
|
|
2022
Q1 | $494K | Buy |
+8,315
| New | +$494K | 0.24% | 79 |
|
|
2015
Q2 | $1.82M | Sell |
15,580
-50
| -0.3% | -$5.85K | 1.7% | 26 |
|
|
2015
Q1 | $1.53M | Buy |
15,630
+560
| +4% | +$55K | 1.43% | 27 |
|
|
2014
Q4 | $1.42M | Buy |
15,070
+6,410
| +74% | +$604K | 1.34% | 30 |
|
|
2014
Q3 | $922K | Buy |
+8,660
| New | +$922K | 0.9% | 32 |
|